Scarica l'app Stockscreener
5.16
3.20%
0.16
Dopo l'orario di chiusura:
4.37
-0.79
-15.31%
Precedente Chiudi:
$5.00
Aprire:
$5
Volume 24 ore:
207.18K
Relative Volume:
12.24
Capitalizzazione di mercato:
$36.94M
Reddito:
$71,000
Utile/perdita netta:
$-2.47M
Rapporto P/E:
-0.1568
EPS:
-32.9143
Flusso di cassa netto:
$-5.24M
1 W Prestazione:
+5.52%
1M Prestazione:
-16.91%
6M Prestazione:
-38.57%
1 anno Prestazione:
-71.80%
Intervallo 1D:
$3.85
$5.19
Intervallo di 1 settimana:
$3.85
$5.19
Portata 52W:
$3.85
$28.44
Pavmed Inc Stock (PAVM) Company Profile
Nome
Pavmed Inc
Settore
Industria
Telefono
(212) 949-4319
Indirizzo
360 MADISON AVENUE, NEW YORK, NY
Compare PAVM vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
5.16 | 36.94M | 71,000 | -2.47M | -5.24M | -32.91 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-03-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-11-05 | Iniziato | Ascendiant Capital Markets | Buy |
| 2018-06-28 | Iniziato | Maxim Group | Buy |
Pavmed Inc Borsa (PAVM) Ultime notizie
PAVmed Inc (PAVMZ) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PAVmed Inc (PAVMZ) Valuation: PE, PB & Fair Value Analysis - TradingKey
PAVmed Inc (PAVMZ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PAVmed Inc (PAVMZ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PAVmed Inc (PAVMZ) Institutional Confidence - TradingKey
PAVmed Inc (PAVMZ) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
PAVmed Inc (PAVM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
PAVmed Inc (PAVM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PAVmed Inc (PAVM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
PAVmed Inc (PAVM) Valuation: PE, PB & Fair Value Analysis - TradingKey
PAVmed Inc (PAVM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PAVmed Inc (PAVM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PAVmed Inc (PAVM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PAVmed Inc (PAVM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Lucid Diagnostics Inc (LUCD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PAVmed Inc (PAVMZ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
PAVmed Inc (PAVMZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PAVmed Inc (PAVM) Institutional Confidence - TradingKey
PAVmed Inc. (PAVM) Edges Higher as Bullish Momentum Builds Above Key SupportEarnings Beat Stocks - newsline.com
Lucid Diagnostics Inc (LUCD) Institutional Confidence - TradingKey
PAVM Maintains Buy Rating -- Price Target Lowered to $56.00 by A - GuruFocus
PAVmed Inc (PAVM) Stock Price & 30 Year Financial Data - GuruFocus
PAVM Technical Analysis | Trend, Signals & Chart Patterns | PAVMED INC (NASDAQ:PAVM) - ChartMill
How The PAVmed (PAVM) Narrative Is Shifting With Reworked Assumptions And A Lower Price Target - Yahoo Finance
PAVM assigns Joseph Virgilio to lead medical device portfolio relaunch - MSN
PAVmed Q1 2026 earnings preview - MSN
PAVM Q1 2026 Earnings: Massive EPS Miss Deepens Concerns as Revenue Remains Nonexistent - thelegaladvocate.com
PAVmed Q1 2026 Earnings: Deeply Negative EPS Surprise Amid Operational ChallengesRevenue Inflection Point - newsline.com
LUCD - Finviz
PAVM Technical Analysis & Stock Price Forecast - Intellectia AI
PAVmed Inc. (PAVM) Gains 2.44% as Stock Tests Key Resistance Near $6.62Size Factor - newsline.com
PAVmed Inc. (PAVM) reports Q1 loss, lags revenue estimates - MSN
PAVM PE Ratio & Valuation, Is PAVM Overvalued - Intellectia AI
Will PAVmed Inc. (PAVM) report negative earnings next week? What you should know - MSN
PAVM|PAVmed Inc|Price:6.390|Chg%:0.04 - TradingKey
Earnings call transcript: PAVmed Q1 2026 sees restructuring gains By Investing.com - Investing.com Nigeria
Earnings call transcript: PAVmed Q1 2026 sees restructuring gains - Investing.com India
Maxim Group Maintains PAVmed(PAVM.US) With Buy Rating, Maintains Target Price $16 - Moomoo
PAVmed Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:PAVM) 2026-05-19 - Seeking Alpha
PAVmed Inc earnings dates,PAVmed Inc earnings estimates - RTTNews
Lucid Diagnostics Inc. (LUCD) reports Q1 loss, misses revenue estimates - MSN
PAVmed Inc. (NASDAQ:PAVM) Q1 2026 Earnings Call Transcript - Insider Monkey
PAVmed Inc (PAVM) Q1 2026 Earnings Call Highlights: Strategic Re - GuruFocus
PAVM Reports Strong Q1 Growth and Financial Position - GuruFocus
PAVmed Inc (PAVM) Q1 2026 Earnings Call Highlights: Strategic Restructuring and Growth ... By GuruFocus - Investing.com Canada
Two Seas Capital (NASDAQ: PAVM) Holds 9.99% of PAVmed, Including Warrants - Stock Titan
PAVM: Restructuring completed; subsidiaries near major milestones and capital structure is simplified - TradingView
PAVmed Inc.Common Stock (NQ: PAVM - FinancialContent
PAVmed (PAVM) Q1 2026 Earnings Transcript - AOL.com
PAVmed Releases Q1 2026 Financial Results - AlphaStreet
Pavmed Inc Azioni (PAVM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):